Posted by undopaminergic on July 4, 2008, at 14:18:51
In reply to Re: Research chemicals - anyone using them?, posted by dbc on July 4, 2008, at 11:25:49
> Friends and my friend SWIM has quite a bit of experience with the tryptamines. SWIM is not a fan of being a guinea pig but once ingested some DOB beliving it to be something else and was not at all pleased with 18 hours of patterned walls and shape shifting shadows, all the usual stuff you would expect.
>
> Shulgin's research was great and quite ballsy of him to say the least but im not sure if the common man should be taking some of these things. The average person shouldnt have access to substances like 2c-i that at 5mg can send you into a mind blowing 8 hour trip.
>
> That whole scene seems to have shifted from tryptamines to stimulant alternatives as of recently since the analogue act really isnt being enforced. Unfortunately this may lead to the gray area of these substances to become much less gray in the eyes of johnny law. College students tripping out on synthetic psyilocybin is a little different than novel stimulant junkies.
>Anything that becomes popular among sufficiently large masses of people will be banned, that's for certain. However, the stimulant-alternatives (e.g. MDPV - methylenedioxypyrovalerone) don't seem to be enjoying such popularity yet.
Of course, my intention wasn't to enquire about alternative recreational substances, but about novel therapeutic agents, for example, research compounds of use in depression or anxiety. Agomelatine would qualify, and other serotonin 5-HT2C-antagonists even more so. Long-acting kappa-opioid receptor antagonists such as nor-binaltorphimine might be another example.
poster:undopaminergic
thread:837957
URL: http://www.dr-bob.org/babble/20080626/msgs/838015.html